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Abstract
Fluid shear modulates many biological properties. How shear mechanosensing occurs in the extracellular matrix (ECM) and
is transduced into cytoskeletal change remains unknown. Cochlin is an ECM protein of unknown function. Our investigation
using a comprehensive spectrum of cutting-edge techniques has resulted in following major findings: (1) over-expression
and down-regulation of cochlin increase and decrease intraocular pressure (IOP), respectively. The overexpression was
achieved in DBA/2J-Gpnmb
+/SjJ using lentiviral vectors, down-regulation was achieved in glaucomatous DBA/2J mice using
targeted disruption (cochlin-null mice) and also using lentiviral vector mediated shRNA against cochlin coding region; (2)
reintroduction of cochlin in cochlin-null mice increases IOP; (3) injection of exogenous cochlin also increased IOP; (4)
increasing perfusion rates increased cochlin multimerization, which reduced the rate of cochlin proteolysis by trypsin and
proteinase K; The cochlin multimerization in response to shear stress suggests its potential mechanosensing. Taken
together with previous studies, we show cochlin is involved in regulation of intraocular pressure in DBA/2J potentially
through mechanosensing of the shear stress.
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Introduction
Fluid shear is a mechanical stimulus experienced by cells and
most organs involved with localized fluid flow. Cellular mechan-
osensing is linked to cytoskeletal remodeling to respond appropri-
ately to altered fluid shear dynamics in single and multicellular
organisms [1].
Fluid flow abnormalities are associated with complex, late onset
progressive diseases such as glaucoma (aqueous outflow), idio-
pathic intracranial hypertension (flow changes in cerebrospinal
fluid) and the non-syndromic hearing disorder DFNA9 [2,3]. IOP
fluctuations likely alter cells of the trabecular meshwork (TM), a
filter like structure in the anterior eye chamber, results in aqueous
outflow dysregulation [4,5]. Cyclic stretch significantly alters TM
gene expression [6]. Regulation of ECM interstitial space is a
major influencing factor for aqueous outflow resistance through
the trabecular meshwork [7]. Consequently the existence of a
mechanosensor (or multiple mechanosensors) to detect fluid shear
changes in the ECM is highly plausible. Cochlin, a secreted
protein of unknown function was identified in glaucomatous but
not normal TM by mass spectrometry and shown to be responsive
to fluid shear [8]. Stretch activated channels (SACs), such as
TREK-1, function as mechanotransducers involved in pressure
regulation [1,9]. Although TREK-1 mRNA is present in the TM,
its role in pressure regulation has not been demonstrated nor has
the involvement of cochlin in mechanosensing. Cochlin expression
have been previously shown to result in co-expression of TREK-1
and filopodia formation [10]. A direct or functional interaction of
cochlin and TREK-1 remains to be demonstrated, however, a
potential functional interaction between cochlin and TREK-1
may exist [10]. We provide evidence here that cochlin is involved
in IOP regulation.
Results
Cochlin Mediates IOP Elevation in Mice
Cochlin was overexpressed in DBA/2J-Gpnmb+/SjJ mice,
which do not develop elevated IOP or glaucomatous neurode-
generation with age, to determine its role in IOP elevation. Mice
injected with COCH transgene with IRES mediated GFP
expressing (COCH-GFP) lentiviral vector into the anterior eye
chamber showed a rise in IOP concomitant with cochlin
expression, reaching a peak between 8–30 days. The IOP remains
elevated upto 35 days post-injection in animals injected at the age
of 6 months (Figure 1A). The IOP returned close to baseline after
about 6 weeks although the cochlin expression remained almost
the same (Figure S1A). The lowering of the IOP is consistent with
lower aqueous production (data not shown) and is consistent with
ciliary body hyalinization and shutdown in the end stages of
glaucoma [11]. Control mice injected with GFP vector alone
(sham) or human serum albumin (HSA) expression vector had no
change in IOP compared to baseline (Figure 1A). Injection of
exogenous cochlin (but not HSA; 10 mg) also results in IOP
elevation in this strain (Figure S1B). IOP elevation with cochlin
overexpression was also found in C57BL/6J mice (Figure 1B).
Immunofluorescence studies confirmed cochlin expression in
COCH-GFP injected eyes, whereas control GFP injected eyes
demonstrated no cochlin expression (Figure 1C). Western blot
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34309analysis of TM extracts corroborated these findings (Figure 1D).
Intracameral injection ensured that transfection covered a large
swath of TM tract. The transfection was verified by detecting the
GFP expression (Figure S1A) and robust GFP expression in vivo in
real time (Figures S1C–S1F). Despite significant IOP elevation, the
hematoxylin-eosin stained sections of COCH-GFP expressing eyes
demonstrate open iridocorneal angles (Figure S1G).
To determine if downregulation of cochlin expression decreases
IOP, cochlin shRNA or control GFP lentiviral vector was injected
into the anterior chamber (Figure 1E) of DBA/2J mice eyes.
Cochlin shRNA injection resulted in decreased cochlin expression
in the angle (Figure 1E). DBA/2J mice normally demonstrate peak
IOP elevation at 8 months of age [12]. Mice injected with cochlin
shRNA at six months of age showed a decrease in IOP and
maintained the decreased IOP level for the next two months
compared to control injected eyes (Figure 1F). Cochlin levels in
DBA/2J mice TM was assessed in vivo using spectral domain (SD)
and recently developed [13] magneto-motive (MM; data not
shown) optical coherence tomography (OCT) demonstrating a
peak expression at 8 months coincident with peak IOPs
(Figures 1G and 1H).
The role of cochlin in IOP elevation and its peak at 8 months
was studied by abrogating cochlin. C57BL/6J mice with targeted
disruption (knockout) of COCH [14] were bred with DBA/2J
mice to derive cochlin2/2 on a DBA/2J background [see
methods for details]. DBA/2J cochlin2/2 mice lacked the
expression of cochlin exons 8, 10 and 11 (Figure 2A). TM protein
extracts (the TM tissue was dissected under microscope, however,
it is likely to retain some contamination from sclera and cornea)
from DBA/2J cochlin2/2 mice lacked cochlin expression in
contrast to its presence in DBA/2J cochlin+/+ and DBA/2J
cochlin+/2 mice (Figure 2B).
Mean IOP rose from 17 to 19.7 mm Hg as DBA/2J cochlin+/+
mice age from 6 to 8 months and then decreased to 12 mm Hg by
12 months of age (Figure 2C), consistent with previous reports
[15]. DBA/2J cochlin2/2 mice had a mean IOP of 10–11 mm
Hg and lacked IOP elevation exhibited by DBA/2J cochlin+/+
mice at 8 months of age. Cochlin expression increases in the
DBA/2J cochlin+/+ mice with age until approximately 8 months
and decreases slightly thereafter (Figure 2D), DBA/2J-Gpnmb+/
SjJ control mice lacked cochlin expression in their TM. Overall
these results suggests concomitant IOP elevation and conversely
maintenance of IOP within normal range in DBA/2J-Gpnmb+/
SjJ and DBA/2J mice is due to cochlin overexpression and down-
regulation, respectively.
Re-introduction of COCH gene expression in DBA/2J
cochlin2/2 mice leads to increased IOP, in contrast to control
GFP injected mice (Figure 2E). Increased expression of cochlin
was commensurate with optic nerve damage as assessed by
paraphenylenediamine (PPD) staining and its down-regulation
prevented IOP associated neurodegeneration (Figures S2A–S2D).
Seventy five percent of the DBA/2J mice developed severe optic
nerve damage at one year. The corresponding number (mice with
severe optic nerve damage) for the DBA/2J cochlin+/2 DBA/2J
cochlin2/2 and DBA/2J-Gpnmb+/SjJ was 5%, 1% and 3%
respectively (Figure S2E). Taken together these results demon-
strate that cochlin plays a key role in IOP elevation in DBA/2J
mice, consistent with its overexpression in human glaucomatous
but not control TM [8]. Cochlin overexpression correlates with
elevated anterior segment pressure (ASP) in monkey and porcine
cultured anterior segments [16,17] and its downregulation results
in decreased IOP in normotensive rabbits [18].
Cochlin is a potental mechanosensing molecule
The fluid flow changes must be sensed by cells in order to
regulate the structure of the TM that allows passage of aqueous
humor and regulate its flow. Aqueous humor is a Newtonian fluid
[19] where the shear force is proportional to multiplicative of cross
section area and rate of fluid flow and inversely proportional to
path length of flow with viscosity acting as proportionality
constant. The difference in the viscosity of aqueous humor and
other factors except flow rate between glaucomatous and non-
glaucomatous eyes has been reported to be insignificant [20]. The
fluid shear or the force experienced by the TM cells is primarily
proportional to the rate of aqueous outflow. The force required for
the keeping the aqueous in flow varies linearly with the flow rate.
The flow rate shows diurnal variation, thus TM cells experience
different fluid shear at different times of the day [21]. Although the
aqueous flow rates for normal and glaucomatous eyes are the same
when the daytime flows are compared, the nighttime flow is
significantly higher in glaucomatous eyes [22]. Though this
increased flow may not have profound effects on TM cells or
ECM over few days, chronic exposure over the years may result in
significant cumulative changes.
Cochlin, at the protein level, possesses a short signal peptide and
two von Willebrand factor A-like (vWFA1 and vWFA2) domains.
The vWFA domain present in ECM proteins is associated with
fluid shear responsiveness [23]. We previously showed that
purified recombinant cochlin is shear responsive [24]. Fluid shear
induces cochlin multimerization (Figure 3A). In an effort to model
the in vivo fluid flow, we used a microsyringe and ultra micro
pump subjecting purified exogenous cochlin to different rates of
fluid flow. Purified cochlin (10 mg) was subjected to flow rates of
2.5 ml/min, 3.0 ml/min or 5.0 ml/min for 50, 100 or 200 cycles of
injection and aspiration (see methods for details). At 2.5 ml/min
the cochlin shows minimal multimerization after 50 or 100 cycles
but shows 2461.5%multimerization after 200 cycles. In contrast,
at 3.0 ml/min the cochlin shows 561.35%, 1562.5%, 7866.8%
multimerization after 50 100 and 200 cycles respectively. At
5.0 ml/min observed cochlin multimerization was 4762%,
8163.8%, and 9364.9% after 50, 100 and 200 cycles respectively
(Figure S3A, S3B). Multimerized cochlin undergoes slower
proteolysis compared to monomeric cochlin (Figure 3B–C).
Cochlin is secreted in the normal TM as well but likely to be
quickly degraded by the proteases. We provide evidence that in
increased fluid shear leads to cochlin multimerization (Figure 3A;
S3). This multimerized cochlin is resistant to proteolysis (Figure 3B,
C) and potentially accumulates in the TM ECM in glaucomatous
eyes. The multimerization of cochlin is consistent with molecular
mechanosensing observed for other proteins such as vWF [25].
Discussion
TM cells function in an environment of continuous varying
mechanical and fluid shear forces [26]. Our understanding of
molecular mechanosensors and their role in transduction of stimuli
into cellular biochemical signals that ultimately regulate cellular
function [25] is very limited. Mechanical forces are possibly
transmitted through protein-protein interactions linking the ECM
via transmembrane proteins to cytoskeletal proteins [27,28].
Fluid shear, cyclic strain and osmotic shock are forms of
biomechanical stress [29] which cause changes in TM gene
expression [6,30]. Reversible multimerization of vWF [23,25] and
cochlin caused by shear stress (Figure 3A; Figure S3) can act as
potential mechanosensing mechanisms [25]. We hypothesize that
normal constitutively secreted cochlin in ECM is eventually
degraded (Figure 3C, D). We found fluid shear fluctuations,
Mechanosensing in Trabecular Meshwork
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e34309Figure 1. Elevated recombinant cochlin expression in mice TM is concomitant with the IOP elevation. (A) DBA/2J-Gpnmb
+/SjJ mice
(n=42–48 for each vector at each time point, as indicated by the symbols) at six months of age were injected with a lentiviral vector bearing the
COCH-GFP transgene or GFP alone (sham) or human serum albumin (HSA) in the anterior chamber (all under the control of a CMV promoter). IOP was
recorded at the indicated time periods. (B) C57BL/6J mice at six months of age were injected with a lentiviral vector bearing the COCH-GFP transgene
(n=20) or GFP alone (n=20) in the anterior chamber. The mice were followed and IOP recorded at the indicated time periods. (C) Representative
immunohistochemical analysis of DBA/2J-Gpnmb
+/SjJ mice eyes injected with COCH-GFP transgene or GFP alone. Top panel shows the anatomy of
the anterior chamber stained with haematoxylin and eosin. SC=Schlemm’s canal, TM=trabecular meshwork; Bar=125 mm Bottom panels show eyes
injected with COCH-GFP or GFP alone as indicated. The brightfield and antibody probing for cochlin (magenta), GFP (green) and merge image has
been shown as indicated. Scale bar=100 mm (D) Western analysis of the TM protein extract of the DBA/2J-Gpnmb
+/SjJ mice injected with GFP alone
or COCH transgene with IRES mediated GFP expression (COCH-GFP). GAPDH has been shown as a loading control. (E) Western analysis of the TM
extracts of DBA/2J mice (8 months old) un-injected control or injected with cochlin shRNA. Coomassie blue stained gel shows total protein loading.
(F) Downregulation of cochlin in DBA/2J cochlin
+/+ mice decreases the mean IOP. DBA/2J cochlin
+/+ mice (n=38–45 for each vector at each point) at
six months of age were injected with a lentiviral vector bearing cochlin shRNA or GFP alone in the anterior chamber. IOP was recorded at the
indicated time periods. (G) Level of cochlin expression in the TM of DBA/2J cochlin
+/+ mice correlates with the IOP. The level of cochlin expression was
quantified at different ages (n=10 at each age group) in vivo using the spectral domain OCT (experimental procedures) and IOP are represented by
hollow and solid symbols respectively. (H) Representative SD OCT image of the anterior chamber angle a 6 month old DBA/2J cochlin
+/+ mice before
(left) and after (right) injection of infra-red (IR-800) dye coupled anti-cochlin antibody. The arrow indicates the region undergoing a change in
intensity of signal before and after injection. The images obtained before and after injection were digitally subtracted for the region of interest (inset).
Error bars (A, B, F and G) depict 6 standard deviation.
doi:10.1371/journal.pone.0034309.g001
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resistant multimeric forms of cochlin (Figures 3A–C; Figure S3).
We propose that shear-induced multimeric cochlin resides for a
longer period in the TM (Figure 3D, E).
We hypothesize that the fluid shear responsive property of
cochlin plays a role in tissue remodeling, in consonance with
transmembrane shear transducing proteins (SACs). Expression of
cochlin has been shown to result in co-expression of an SAC,
TREK-1 in the primary TM cells [10]. In the inner ear protein
extract, cochlin has been shown to co-precipitate with solute
transporter slc44a2 [31]. A direct or functional interaction with
either TREK-1 or slc44a2 is yet to be shown in the TM cells. We
Figure 2. Down-regulation and/or disruption of cochlin expression in mice TM is commensurate with reduction in mean IOP. (A)
Agarose gel (1.2%) showing the absence of PCR products for exons 8, 10 and 11 in the DBA/2J cochlin
2/2 mice. These exons are present in DBA/2J
cochlin
+/+ and cochlin
+/2 mice. DNA was isolated from mice tail and subjected to PCR amplification for the indicated exons. (B) Western blot analysis
of TM extract of DBA/2J cochlin
+/+, DBA/2J cochlin
+/2 and DBA/2J cochlin
2/2 mice showing the complete absence of cochlin in DBA/2J cochlin
2/2
mice. Coomassie blue stained gel shows equal loading of protein in all the lanes. (C) Intraocular pressure (IOP in mmHg) in different mice strains at
indicated ages (n=35–45 for each strain at each age group). The DBA/2J cochlin
+/+ mice show a higher mean IOP as compared to DBA/2J-Gpnmb
+/
SjJ, DBA/2J cochlin
+/2 and DBA/2J cochlin2/2 mice at 6 months and at 8 months of age. The difference is most marked at 8 months of age. By 12
months, the mean IOP is similar for the different strains. (D) Western blot analysis of the TM protein extract from the DBA/2J cochlin
+/+ and DBA/2J-
Gpnmb
+/SjJ at the indicated ages, probed for cochlin. GAPDH has been shown as a loading control. (E) Generation 10 (Gen 10) DBA/2J cochlin
2/2 at
six months of age were injected with a lentiviral vector bearing the COCH-GFP transgene (n=20) or GFP alone (n=20) in the anterior chamber. The
mice were followed and IOP recorded at the indicated time periods. Error bars (C and E) depict 6 standard deviation.
doi:10.1371/journal.pone.0034309.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34309Figure 3. Cochlin mechanosensing and proposed model of potential associated TM changes. (A) Western analysis of purified
recombinant cochlin (*) using anti-cochlin antibody before after sheer stress, revealing shear stress-induced mulitmers. Cochlin was subjected to fluid
shear of 3 ml/min for 150 cycles. (B) Comparison of proteolytic digestion (in percentage) of native (left side) and multimerized (right side) cochlin by
trypsin (open bars) and proteinase K (filled bars) showing slower digestion of multimerized cochlin. Digestion of multimerized and native cochlin
(10 mg) was performed using 0.01 mg/10 mg Trypsin or 0.05 mg/10 mg Proteinase K. After incubation at room temperature, the samples were boiled
using 1 mM DTT at 100uC for 1 minute and analyzed on SDS-PAGE. Densitometric analyses data from three independent experiments (mean6
standard deviation) has been presented. (C) A representative Western analysis of native and multimerized cochlin subjected to subcatalytic amounts
of trypsin and proteinase K digestion for 10 minutes at room temperature. Purified recombinant cochlin (*), native monomeric cochlin and multimeric
cochlin (initial amount 1 mg) has been depicted as Mo and Mu respectively. Digestion was performed by 0. 1 mg/10 mg Trypsin or 0.5 mg/10 mg
Proteinase K. Digestion was stopped by heating at 100uC, separated on a 10% reducing SDS-PAGE and probed with chicken polyclonal antibody
against cochlin. Proposed model of cochlin mechanosensing and associated global change in TM. (D) Illustration depicting that the cochlin
constitutively secreted by the normal TM cells is degraded by the proteases (dashed lines denoting degraded proteins). (E) Cochlin in the presence of
fluctuating shear stress (or elevated divalent cations), forms multimers which are resistant to proteolysis. Multimerized cochlin may potentially
interact with the transmembrane proteins TREK-1 or slc44a2 either directly, functionally, or indirectly leading to events that may result in cytoskeletal
reorganization. (F) Confocal microscopy image showing the sieve like structure of TM (arrow). A representative area of TM with rectangular
arrangement of cells is highlighted by a yellow box. SC=Schlemm’s canal; TM=trabecular meshwork. The magnified view of rectangular
arrangement of cells highlighted by a yellow box also has been shown. (G) The line diagram depicts the filter like structure of the TM. A magnified
view mimicking one such rectangle as in (F) with an additional cell in the middle of the rectangle has been shown. Notice the change in orientation of
Mechanosensing in Trabecular Meshwork
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34309propose that mechanosensing and mechanotransduction may
induce alterations in cell shape and motility within the TM.
Cultured primary human TM cells demonstrated syn-expression
of cochlin and TREK-1 in the filopodia at the very initial stages at
the leading edges of the protrusions [10]. Voltage sensitive dye,
bis-(1, 3-dibutylbarbituric acid) trimethine oxonol (DiBAC) intake
studies [32] further showed that TREK-1 interaction with cochlin
is functional resulting in activation of TREK-1 channel and
concomitant changes in TM cell shapes [10]. TREK-1 mediated
morphological changes in endothelial cells were shown to be
independent of its channel activity [33], which is similar for TM
cells as well [10]. Cellular level syn-expression and functional
interaction of cochlin and TREK-1 is consistent with their role in
mechanosensing and mechanotransduction. Mechanosensing in-
duced changes in cell shape and motility should create open spaces
for fluid outflow. Potential modulation of cell shape and motility
and overall space expansion mediated by cochlin should induce
overall TM filter changes and result in increased fluid flow.
SACs (TREK-1) are activated by shear and osmolarity [34] and
they contribute to pressure regulation in the kidney and the
cardiovascular system [35]. Although TREK-1 as well as slc44a2
mRNA are present in TM cells (Unigene), however, they have not
been implicated in aqueous outflow or pressure control in the TM.
Our findings implicate ECM mechanosensing by cochlin with
potential transmembrane mechanotransduction. Our results
suggest mechanotransduction by cochlin possibly involving
TREK-1 [10] of fluid flowing through the ECM. Such mechan-
otransduction can potentially modulate the expression of several
cytosolic proteins, for example, profilin I, which in turn may cause
cytoskeletal remodeling [36] concomitant with increased outflow
facility [37] and fluid flow resulting in reduction of IOP [38,39].
We propose a model where such mechanosensing and
mechanotransduction enables some TM cells (Figure 3F) to
undergo minor orientation changes in the TM aqueous filter
(Figure 3G). Within the filter-like TM arrangement (Figure 3F),
some cells secrete cochlin and enable a cell to undergo incremental
change in orientation which increase fluid outflow (Figure 3G;
space opening indicated by dashed arrows). We envisage that
when these incremental orientation changes are not sufficient,
coordinated movements of cells in oblique and horizontal planes
occur and open additional fluid escape routes (Figure 3H; arrows
and arrowhead indicate newly opened space). We predict that
concerted changes in many cells simultaneously will result in
overall change across the TM (Figure 3I). Observed cochlin and
TREK-1 co-expression [10] are consistent with role of mechan-
osensing and mechanotransduction molecules and initiation of
these changes (Figures 3D–3I). Once initiated, further and
progressive cellular changes result in TM remodeling and likely
enhanced fluid flow across cell layers. Maximum resistance to
aqueous outflow is localized to the juxtacanalicular tissue of the
TM [40]. Studies suggest TM cells dynamically regulate outflow
facility by rearranging their cytoskeleton, thus enhancing aqueous
outflow [41].
We also found that prolonged overexpression of cochlin results
in formation of cochlin deposits in cell culture (Figure 3J, i) that
resembles cochlin deposits observed in vivo (Figure 3J,ii). We also
found that frequent fluctuating fluid shear result in similar
formation of cochlin deposits in vitro (Figure 3K) that resembles
in vivo cochlin deposits (Figure 3J,ii). We used an Ussing type
chamber attached to a peristaltic pump was used to apply shear
stress equivalent to that experienced by TM cells when subjected
to a flow rate of 3.0 ml/min (Figure 3K). Presence of deposits have
been reported in collector channels in glaucomatous eyes [42].
Such collector channel blockage augmented by contributions from
various factors, such as fluctuating fluid shear and oxidative stress,
lead to an irreversible progressive pathological state in the eye such
as glaucoma [43], a family of late onset irreversible blinding optic
neuropathies affecting over 60.5 million people worldwide [44].
Elevated IOP and diurnal fluctuation in IOP [5] are major risk
factors in glaucoma. TM cells in glaucomatous eyes experience a
significant level of fluid shear change due to IOP fluctuation. IOP
reduction acts as a neuro-protectant delaying glaucoma progres-
sion [45]. The development of drugs which increase aqueous
drainage via the TM pathway is needed. The present work shows
involvement of cochlin in regulation of intraocular pressure likely
by modulating TM outflow. In the future further detailed
mechanistic insight along these lines may lead to development of
more efficacious intervention strategies.
Materials and Methods
Ethics Statement
The work was conducted adhering to the guidelines of the
Institute Review board of the University of Miami. All human
samples were handled in keeping with the principles expressed in
the Declaration of Helsinki. All experiments with the human
samples were conducted at the SKB lab and the protocol was
approved by the Institute Review board of the University of
Miami. A written informed consent was obtained from all patients
undergoing trabeculectomy for POAG and donating the tissue so
obtained for research. Cadaveric human eyes were obtained from
Bascom Palmer Eye Bank with the approval of Institute Review
board of the University of Miami. Human TM cell culture
protocol was approved by the Institute Review board of the
University of Miami.
Tissue Procurement and Mice Housing
Adult mice from inbred strains DBA/2J and DBA/2J-
Gpnmb
+/SjJ were obtained from the Jackson Laboratory (Bar
Harbor, ME). Mice with targeted cochlin knockout allele [14]
were bred onto the DBA/2J background to produce DBA/2J
cochlin
+/2 and DBA/2J cochlin
2/2 mice. We established colonies
of DBA/2J, DBA/2J cochlin
+/2, DBA/2J cochlin
2/2 and DBA/
2J-Gpnmb
+/SjJ mice at the Animal Facility of the University of
Miami, Miller School of Medicine (Miami, FL), in a controlled
environment under a Institutional Animal Care and Use
Committee (IACUC) approved protocol. The animals were
maintained in rooms with 12 h light/dark cycles and fed ad
libitum. TM tissue samples were carefully removed surgically
under a dissecting microscope by a trained ophthalmologist
the middle cell opens up interstitial space for additional fluid flow indicated by dashed arrows. (H) When incremental space opening is insufficient,
larger orientation changes by cells in the middle and those forming rectangle are necessary to increase fluid flow. Newly opened space is indicated by
arrow head. The dark lines and dark dashed lines are to indicate orientation changes. (I) Cartoon illustrating concerted orientation changes in several
individual cells (dashed lines) leading to a global change in the structure of the sieve like TM. (J) Confocal microscopy image of cochlin transfected TM
cells (left; i) expressing cochlin (pink) and tiny aggregates of cochlin (arrows) secreted into the media. These small cochlin aggregates coalesce (arrow)
to form larger deposits as shown in human glaucomatous TM probed for cochlin (green; right; ii). Scale bar=25 mm (left) and 50 mm (right). (K)
Confocal microscopy image of trilayer of cochlin transfected TM cells on a PVDF membrane exposed to continuous fluctuation in fluid shear stress in
an Ussing type chamber showing the development of cochlin deposits (red; arrows).
doi:10.1371/journal.pone.0034309.g003
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procedures approved by the IACUC (protocol numbers 06-027;
09-008; IBC 06-007; 09-001).
Human eyes from normal and POAG donors, all between 40
and 85 years of age (Table S1), were used in this study, and were
obtained through the Bascom Palmer Eye Bank (BPEI) and
National Disease Research Interchange (NDRI). The protocol for
use of human tissue was approved by the Institutional Review
Board of the University of Miami. Eyes were enucleated within
12 h of death and stored at 280uC until TM tissue was isolated by
dissection. Normal control eyes were from donors with no visual
field defects, no evidence of glaucoma, and without central
nervous system abnormalities. Fixed human TM tissues used for
immunohistochemistry were obtained from the Eye Donor
Program of the Foundation Fighting Blindness (Owings Mills,
MD). Glaucomatous eyes and tissues were from clinically
documented POAG donors. Glaucomatous TM tissues (,1–
2m m
3) were obtained by trabeculectomy from POAG patients in
the BPEI and Mundorf Eye Center (Charlotte, NC) with
institutional review board approval. Human tissue obtained by
trabeculectomy consisted predominantly of TM; however, possible
contamination with small amounts of surrounding tissue (e.g.
sclera) cannot be excluded. TM cells for cell culture were isolated
from the rim tissue associated with corneas used for transplanta-
tion at the BPEI and were obtained from healthy human eyes
within 3 h of death and stored until use in Optisol-GS medium
(Chiron Vision, Claremont, CA).
Intraocular Pressure Measurement
The mice were anaesthetized using intraperitoneal injection
(0.1 ml) of ketamine (100 mg/kg) and xylazine (9 mg/kg). One
mouse was anaesthetized at a time and IOP was measured as soon
as the mouse failed to respond to touch. All care was taken to
ensure that the mice were in a similar level of anesthesia when the
IOP measurements were made. To measure the IOP, hand held
tonometer, TonoLab (Colonial Medical Supply, Franconia, NH)
was used. To ensure accuracy of the measurements, TonoLab
measurements were confirmed using anterior chamber cannula-
tion as described previously [12] in a subset of mice. The two IOP
measurement methodologies correlated very closely in most cases.
Quantification of Cochlin Expression in Mice TM Using
Western Blot Analysis
Mice were euthanized at the indicated ages and the eyes were
immediately enucleated. TM was dissected out of the enucleated
eyes under a dissecting microscope by a trained ophthalmologist.
Such dissected tissue can have contamination from surrounding
tissue. Previously with immunohistochemistry we have shown the
presence of cochlin largely to remain confined to TM [24]. Each
mouse TM sample was used for preparation of protein extract
individually and analyzed individually. Thus obtained TM was
finely minced and proteins were extracted using 50 mM Tris-HCl,
pH 7.5, 125 mM NaCl and 0.1% genapol (cat# 345794, EMD
Biosciences, La Jolla, CA).The protein extract was subjected to
Western blot analysis. For Western blot the proteins were
separated on 4–20% Tris-glycine gel (cat# EC6028BOX,
Invitrogen, Carlsbad, CA) and then transferred to polyvinylidene
fluoride membranes (PVDF) (cat# 162-0219, BioRad Labratories,
Hercules, CA). For cochlin identification, custom chicken
polyclonal antibodies against cochlin peptides (KR LKK TPE
KKT GNK DC from cochlin coding region 147–162 designated
as hCochlin# 1; ZCZ TYD QRT EFS FTD YST KEN; from
cochlin coding region 412–429 designated as hCochin#2; and CZ
DDL KDM ASK PKE SH from cochlin coding region 358–371
designated as hCochlin#3, Aves labs Inc., Tigard, OR) were used
[3]. A secondary antibody conjugated to horseradish peroxidase
(goat anti-chicken cat# H-1004, Aves Labs Inc.) was added and
proteins were detected using enhanced chemiluminescent sub-
strate (cat# 32106, Pierce Thermo Fisher Scientific Inc, Rockford,
IL). GAPDH (anti-GAPDH cat# ab22556, Abcam, Cambridge,
MA) was used as a loading control.
Optic Nerve Analysis
Mice were euthanized at 12 months of age and the eyes were
immediately enucleated and fixed in 2% Glutraldehyde and left
overnight at 4uC. To asses for glaucomatous damage, the optic
nerves were sectioned and subsequently stained with paraphenyl-
enediamine (PPD) Images were taken using Zeiss Axiostar Plus
CYL#621 microscope (Carl Zeiss Microimaging Inc, Thornwood,
NY).
To quantify the percentage of mice suffering from mild,
moderate or severe optic nerve damage, PPD stained sections of
each mouse were graded by three observers in a blinded fashion
independent of each other. Three sections from each mouse
(n=25 in each group) were graded and given a score of 1–10 with
one being the least severe and ten being the most severe damage.
The scores from the two observers were averaged. Mice getting a
final score of 0–4 were labeled as having mild damage, 5–7
moderate damage and 8–10 severe damage.
Mice Intraocular Injections
Mice were anaesthetized as for IOP measurement. A topical
anesthetic (tetracaine hydrochloride 0.5%, Bausch & Lomb) was
applied to the desired eye. 1 ml of the lentiviral vector bearing the
gene of interest (COCH-GFP transgene, GFP alone or cochlin
shRNA) was injected using a 36G beveled needle (cat# NF36BV-
2, World precision instrument, Sarasota, FL) mounted on 10 ml
microsyringe (cat# NanoFil 300329, World precision instrument).
An UltraMicroPump II (World precision instrument’s UMP2 and
UMC4) was used to precisely control the volume of injection. The
needle was entered at the limbus and care was taken not to
traumatize the iris or the lens. Mice with injury to iris or lens were
excluded from the study. As the needle was withdrawn after
injection, a cotton tip applicator was applied for about 1 minute to
prevent the virus/aqueous reflux.
Mice Genotyping
C57BL/6J mice with targeted disruption (knockout) of COCH
[14] were bred with DBA/2J mice to derive cochlin
+/2 on a
DBA/2J background. C57BL/6J cochlin knockout mice were
generated by eliminating exons (7–11) corresponding to amino
acids 147–552 encompassing cochlin vWA domains [14].
Heterozygotes (cochlin
+/2) were subsequently bred to derive
cochlin
2/2 (cochlin KO) in a DBA/2J background. The
genotyped disrupted cochlin allele was bred into a DBA/2J
background for greater than 10 generations to generate cochlin
deletion in a DBA/2J background. The 10
th generation cochlin
2/
2 so obtained were labeled as Gen 10. DNA isolated from the
mice tail was subjected to PCR amplification for exons 4, 5, 8, 10
and 11 at each generation.
Mice were anaesthetized as described above for IOP measure-
ment. Genotyping was performed on mice approximately 3 weeks
of age. Mice tails were tattooed (AIMS, ATS-3 general rodent
tattoo system) for identification. Then 2.5–3.0 mm of tail was
clipped. The tail was cauterized using Kwik-Stop styptic powder
for hemostasis. Three hundred ml of Lysis reagent (Direct PCR-
Tail, cat#102-T, Viagen Biotech, Los Angeles, CA) and 9 mlo f
10 mg/ml proteinase-K solution (cat# P6556, Sigma-Aldrich, St.
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at 55uC. The following morning the tail samples were heated for
45 minutes at 85uC. DNA isolated from the tail was then subjected
to polymerase chain reaction (PCR) amplification for exons 4, 5, 8,
10 and 11. PCR products were run on a 1.2% agarose gel (Ultra-
pure agarose, cat# 16500-100, Invitrogen) to assess for the
presence of the above exons. Following primer pairs were used for
identifying DBA/2J cochlin
2/2 mice:
Exon 4: Sense: 59-CCATTCCTGTCACCTGCTTT; Anti-
sense: 59-ATGCTGGACACTGACGCATA.
Exon 5: Sense: 59-GGAGTGATTGGCACCTCAG; Antisense:
59-TCGGGAAAGCATCTGAGACT.
Exon 8: Sense: 59-GGCAGACATTGCATTTCTCA; Anti-
sense: 59-ACGTGTGGTCCTTCTGTTCC.
Exon 10: Sense: 59-AAAGCCTTGAAGCACACTGC; Anti-
sense: 59-CTTGTCAACAAATGCAACATCT.
Exon 11: Sense: 59-ATCACATGCCCAACTGGTTT; Anti-
sense: 59-GCCTCGGACATCATCATAGG.
The sizes of different exons are as follows Exon 4: 157 bp, Exon
5: 134 bp, Exon 8: 148 bp, Exon 10: 227 bp and Exon 11:
517 bp.
The cochlin KO mice were bred onto DBA/2J background for
10 generations (Gen10) as described below:
Step 1. Crossed DBA/2J Coch
+/+ X Coch KO
{ to obtain Gen1
(Heterozygote Coch
+/2)
Step 2. Crossed Gen1 X Gen1 to get Gen1*
Step 3. When Gen1* is genotyped and its KO status was
established, it was termed as Gen1 KO.
Step 4. Crossed Gen1KO X DBA/2J Coch
+/+ which was
termed Gen2
Step 5. Crossed Gen 2 X Gen 2 to get Gen2*
Step 6. When Gen2* is genotyped and its KO status was
established, it was termed as Gen2 KO.
Step 7. Crossed Gen2KO X DBA/2J Coch
+/+ which was
termed Gen3
Step 8. Repeated steps 4 to 7 till Gen 10 KO has been obtained.
({ Coch KO was obtained as a research gift from Dr. C. Stewart
at National Institutes of Health [14]).
Quantification of Shear Stress And Cochlin
Multimerization
Cochlin was purified according to the established protocols [3].
10 mg of the purified exogenous cochlin was taken and subjected to
fluid shear using a 10 ml microsyringe (cat# NanoFil 300329,
World precision instrument) and UltraMicroPump II (World
precision instrument’s UMP2 and UMC4). The flow was adjusted
to 2.5 ml/min or 3.0 ml/min or 5.0 ml/min was maintained for 50
or 100 or 200 cycles of injection and aspiration at each of the flow
rates. The injection and aspiration flow rates were identical, all
operations were performed at a constant temperature of
2560.5uC (room temperature was controlled at this level during
these experiments) the samples were emptied into an eppendorf
tube. The protein samples so obtained were subjected to Western
blot analysis and the extent of multimerization was quantified by
densitometric analysis. Protease digestion of multimerized and
native cochlin (10 mgo r1mg) was performed using either 0.1 mg/
10 mg or 0.01 mg/10 mg Trypsin (sequencing grade porcine
trypsin; catalog#V5111 Promega Corporation, WI) or 0.5 mg/
10 mg or 0.05 mg/10 mg Proteinase (catalog#25530-015, Invitro-
gen, Carlsbad, CA) in buffers recommended by the manufacturer.
After incubation at room temperature, the samples were boiled
using 1 mM DTT at 100uC for 1 minute and analyzed on SDS-
PAGE.
Shear force (F)=g Av/l, for aqueous humor, where g is the
viscosity of the fluid, A is the cross sectional area of the chamber
through which the fluid is flowing and l is the length of the
chamber. The factor l for aqueous humor is the distance between
the ciliary epithelium and the episcleral veins. For aqueous humor
outflow whether in normal or in glaucomatous eyes, g, A and l
remain constant. The flow rate (v) is the greatest determinant of
fluid shear or Force.
Immunohistochemistry
DBA/2J-Gpnmb
+/SjJ mice were euthanized and the eyes were
enucleated immediately. The globes were fixed using 4%
paraformaldehyde (cat# 19943, USB Corp, Cleveland, OH)
overnight, washed with 1XPBS 3 times for 10 m per wash, placed
in 15% sucrose for 4 h and then switched to 30% sucrose for
another 4 h. The globes were then placed in a cryomold (cat#
Tissue-Tek 4565, Sakura Finetek, USA) and embedded in O.C.T.
(Optimum Cutting Temperature) compound (cat# Tissue-Tek
4583, Sakura Finetek, USA) using liquid nitrogen. The embedded
globes were then sectioned and subjected to immunohistochemcal
analysis probing for cochlin (hCochlin#3, Aves Labs Inc.) and
GFP (cat#, 600-301-215 Rockland Immunochemicals Inc.,
Gilbertsville, PA).
Cochlin Transgene and Cochlin shRNA Lentivirus
Production
To overexpress cochlin in the TM of congenic DBA/2J mice,
cochlin transgene lentivirus was constructed in the HEK-293T
[cat# 293T/17 (CRL-11268), ATCC, Manassas, VA] cells.
Cochlin expression clone (cat# EX-Q0226-Lv31, GeneCopoeia
Inc., Rockville, MD) was packaged into a lentiviral vector by using
the Lenti-Pac FIV expression packaging kit and the protocol
provided by the manufacturer. This protocol typically yielded
10
7 ifu/ml of the recombinant lentivirus. The COCH gene used to
make the COCH expression vector was human (NM_004086).
To down-regulate cochlin expression in the TM of DBA/2J
mice cochlin shRNA was constructed in HEK-293T cells using the
Trans-Lentiviral
TM GIPZ Packaging System (cat# TLP4614,
Open Biosystem, Huntsville, AL) and the protocol provided by the
manufacturer. This typically yielded a viral stock of 10
8
tranduction unit (TU)/ml. For control experiments a lentiviral
vector expressing GFP was constructed in a similar fashion. The
shRNA used was set of 5 clones. The sequence of the clones used is
shown below.
TGCTGTTGACAGTGAGCGCGGGCAGCGCCGATTTA-
ATTTATAGTGAAGCCACAGATGTATAAATTAAATCGGC-
GCTGCCCATGCCTACTGCCTCGGA (catalog no. V2LHS_
172911);
TGCTGTTGACAGTGAGCGCGCTTCTTTCACAGTAAC-
TAAATAGTGAAGCCACAGATGTATTTAGTTACTGTGAAA-
GAAGCATGCCTACTGCCTCGGA (catalog no. V2LHS_1729
09);
TGCTGTTGACAGTGAGCGCCAGGTAAACGACTAAA-
GAAAATAGTGAAGCCACAGATGTATTTTCTTTAGTCG-
TTTACCTGTTGCCTACTGCCTCGGA (catalog no. V3LHS_
369645);
TGCTGTTGACAGTGAGCGAACGGTAGATGCTGGAG-
TAAGATAGTGAAGCCACAGATGTATCTTACTCCAGCA-
TCTACCGTGTGCCTACTGCCTCGGA (catalog no. V3LHS_
369649);
TGCTGTTGACAGTGAGCGATCGGACATTGGTGCCA-
AGATATAGTGAAGCCACAGATGTATATCTTGGCACCA-
ATGTCCGAGTGCCTACTGCCTCGGA (catalog no. V3LHS_
369647).
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Primary human TM cells were cultured from cadaveric corneo-
scleral sections obtained from the Bascom Palmer Eye Bank
(BPEI) and Mundorf Eye Centre (Charlotte, NC). The cells were
isolated through a blunt dissection of the area containing and
adjacent to the canal of Schlemm, followed by 2 h digestion in 1X
PBS (cat# 21-030-CV, Mediatech Inc.) suspension of 20%
0.01 mg/ml collagenase-A (cat# LS004194, Worthington, Lake-
wood NJ). The blunt dissection and the proteolytic treatment were
performed inside a 12 well culture plate (cat# 665-180 Greiner
Bio-One, Neuburg, Germany). Culture media containing
[DMEM 1X (cat# 10-017-CM, Mediatech Inc.), 10% heat
inactivated fetal bovine serum (FBS) (cat# 35-016-CV, Mediatech
Inc.), 0.5% 1.7 mM L-Glutamine (cat# G6392, Sigma-Aldrich),
1% Antibiotic-Antimycotic solution (cat# 30-004-CL, Mediatech
Inc.)] was added after 2 h to terminate digestion. A sterile
microscopy slide (cat# 56700-194, VMR) was placed on top of the
tissue fragment to ensure bottom-contact and immobility inside
the media well. The sections were cultured at 37uC, 5% CO2 cell
culture incubator. Culture was washed with 1X PBS 7 days later to
remove tissue debris; media change occurred every 3–4 days. Thus
obtained cells were trypsin treated (cat# 25-050-Cl, Mediatech
Inc.) and accordingly distributed the day before the transfection.
Transfection complexes were created using a ratio of 0.4 mg/mlo f
respective vector DNA to the transfection agent (Lipofectamine
2000, cat# 11668-019, Invitrogen), prepared according to the
manufacturer’s instructions. Following the addition of the
complexes to the selected culture wells, the transfection reactions
were allowed to take place over a 2.5 h span, after which they
were terminated through the addition of cell culture media.
Trabecular meshwork cells were cultured as described above on
the PVDF membrane. Before plating the cells, a layer of collagen
matrix (,0.1 mg per layer; Rat Tail Collagen, cat# 354249, BD
Biosciences, San Jose, CA) was formed on the membrane to
facilitate cell adherence. The cells were allowed to form a
confluent monolayer over a period of 16–24 h, following the
addition of another layer. This process was repeated to ultimately
achieve a confluent tri-layer of cells. Primary TM cells of the each
layer for all multilayer cell containing experiments were
transfected as described previously [10].
To demonstrate the formation of cochlin deposits in vitro,
cochlin transfected TM cells were cultured on a PVDF membrane
(Pall Life Sciences) with a pore size of 0.45 mM in a series of three
confluent layers as described above. The membrane was then
placed between the two hemi-vessels of the Ussing-type chamber
connected to a standing column of serum-free cell culture media
(DMEM 1X, Mediatech Inc) which was allowed to pass through
the membrane by gravity, producing shear stress upon the cell
layers as a result of the passage. Thus arranged setup was
maintained for 12 h, following which the membrane was
embedded in optimum cutting temperature medium and solidified
using liquid nitrogen to permit sectioning. Obtained sections were
subjected to immunohistochemical analysis probing for cochlin
protein using cochlin primary antibody (usually hCochlin#3, Aves
Labs Inc.), followed by respective secondary antibody incubation
(A647: A21449, Invitrogen) and imaged using the confocal setup
(Leica TSP5; DM6000 B).
Spectral Domain Optic Coherence Tomography (SDOCT)
Mice were anaesthetized as for IOP measurement and a drop of
topical anesthetic (tetracaine hydrochloride 0.5%, Bausch &
Lomb, Tampa, FL) was applied to the desired eye. Custom
generated 2 ml anti-cochlin antibody (hcochlin#3, Aves Labs Inc.),
coupled to an infra-red dye with an absorption peak at 800 nm
(cat# CUST154, Rockland Inc.), was injected into the anterior
chamber of mice eyes. The anesthetized animals were restrained
on a mounting tube, which was fixed on a 6-axis movable platform
for imaging. An ultra-high resolution (,3 mm) SDOCT was used
to scan the mouse. The mice were imaged before injection and
30 minutes post-injection using the SDOCT. This analysis was
performed on 3, 6, 8 and 12 month old DBA/2J mice. The images
obtained before and after injection were subtracted digitally and
the resultant images were analyzed for quantifying the OCT signal
intensity using NIH ImageJ (v.1.43u) software which is represen-
tative of the amount of cochlin present. We imaged 10 mice each
at 3, 6, 8 and 12 months of age. The maximum signal intensity
(found in mice at 8 months) was regarded as 100% and all the
readings are expressed relative to this intensity.
In Vivo Imaging of GFP in TM
DBA/2J-Gpnmb
+/SjJ mice injected with the lentiviral vector
bearing the COCH-GFP transgene (GeneCopoeia Inc.) were
imaged to document the GFP expression in-vivo. Images were
taken before injection as well as, 1 and 2 weeks post-injection.
Images were taken with the Micron III Microscope (Phoenix
Research Laboratories, Inc, San Ramon, CA) with a trabecular
meshwork (TM) attachment. The TM attachment consists of a 5-
Watt white light LED source, filter wheel, and gonio-prism
specifically designed for mice (Ocular Instruments, Inc., Bellevue,
WA). Hypromellose solution (cat# NDC 17478-064-12, Akorn,
Lake Forest, IL) was used as a coupling fluid between the camera
lens and the cornea. Images obtained were subjected to uniform
background subtraction.
Supporting Information
Figure S1 COCH-GFP transgene injection leads to
cochlin expression in-vivo. (A) Western analysis of the TM
protein extract (10 mg) of the DBA/2J-Gpnmb+/SjJ mice injected
with COCH transgene on days 7, 21 and 42 post-injection.
GAPDH has been shown as a loading control. The lower panels
indicate Western blot from control animals as indicated. (B) DBA/
2J-Gpnmb+/SjJ mice (n=45) at six months were injected (1 ml)
with 10 mg of purified human serum albumin (HSA), Cochlin or
PBS (sham) in the anterior chamber as indicated every 72 hours
up to 44 days. (C) Image of a living mouse anterior chamber angle
showing the cornea, iris and the TM (arrow). (D–F) In vivo
imaging of GFP expression in mice TM. Before COCH-GFP
injection [DAY 0, (D)] no fluorescence is seen in the TM but at
DAY 7 (E) and DAY 14 (F) post-injection, GFP expression (arrow)
can be visualized. (G) Hematoxylin-eosin stained images of DBA/
2J-Gpnmb
+/SjJ mice anterior chamber angle un-injected (left) or
injected (right) with COCH-GFP transgene bearing lentiviral vector
demonstrating an open iridocorneal angle in either case. Scale bar,
50 mm.
(TIF)
Figure S2 Increased optic nerve damage in DBA/2J
cochlin
+/+ mice as a consequence of elevated IOP. (A–D)
Paraphenylenediamine (PPD) stained optic nerve sections (20X)
show axonal death in mice. A representative PPD stained optic
nerve section of 12 month old (A) DBA/2J cochlin
+/+ (B) DBA/2J
cochlin
+/2 (C), DBA/2J cochlin
2/2 (D) and DBA/2J-Gpnmb
+/
SjJ (E) frequency of optic nerve damage in mice at 12 months of
age. Comparison of percentage of mice showing mild, moderate or
severe optic nerve damage among the different strains of mice as
indicated.
(EPS)
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shear. (A) Comparison of percentage of cochlin showing multi-
merization when subjected to different levels of fluid shear as
indicated. The purified recombinant cochlin was subjected to
different flow rates 2.5–5.0 ml/min for 50–200 cycles as indicated.
Densitometric scan from four independent experiments were used
to calculate mean6 standard deviation, which has been presented
here. (B) A representative Western blot analyses of control [not
subjected to shear stress (*); as indicated] and cochlin subjected to
shear stress as indicated. The purified cochlin was subjected to flow
rates of 2.5–5.0 ml/min as indicated for 50–200 cycles as indicated.
(EPS)
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